Skip to main content
SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc. — Investor Relations & Filings

Ticker · SLS ISIN · US81642T2096 LEI · 549300VZIH50VYURLQ98 US Manufacturing
Open in API
Filings indexed 1,071 across all filing types
Latest filing 2011-02-28 Capital/Financing Update
Country US United States of America
Listing US SLS

About SELLAS Life Sciences Group, Inc.

https://www.sellaslifesciences.com/

SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's core activity involves advancing its pipeline of cancer immunotherapies, which are designed to utilize the patient's immune system to combat various malignancies. Its development programs aim to address significant unmet medical needs in oncology by creating new treatment options for cancer patients.

Recent filings

Filing Released Lang Actions
424B5
Capital/Financing Update Classification · 95% confidence The document is a preliminary prospectus supplement and accompanying prospectus related to an offering of common stock and warrants by RXi Pharmaceuticals Corporation. It includes detailed information about the securities being offered, risk factors, use of proceeds, underwriting, and legal matters. The document is filed pursuant to Rule 424(b)(5), which is a SEC rule related to prospectus supplements for securities offerings. This type of document is a capital markets filing that provides updates on fundraising activities and terms of the offering. It is not a financial report, earnings release, or management discussion, nor is it a regulatory filing unrelated to capital raising. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief notice, so it is not a Report Publication Announcement or Regulatory Filing fallback. Hence, the classification is CAP with high confidence.
2011-02-28 English
SC 13G/A
Major Shareholding Notification
2011-02-09 English
Regulatory Filings 2011
Regulatory Filings
2011-01-20 English
FORM 4 SUBMISSION
Director's Dealing
2011-01-14 English
FORM 4 SUBMISSION
Director's Dealing
2011-01-14 English
FORM 4 SUBMISSION
Director's Dealing
2011-01-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.